ResearcherChang Gung UniversityNo recent work listed

Keng-Hao Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5011994790. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 3

External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line chemotherapy: A multi-institute experience… Co-author DOI 10.1016/j.pan.2019.11.001 ↗
Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. Co-author DOI 10.3390/jcm8091402 ↗
Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. Co-author DOI 10.1097/md.0000000000004191 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu‐Shin Hung · 2 shared papers, 2019–2020 · strength 0.19
- Paper External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line ch… DOI 10.1016/j.pan.2019.11.001 ↗
- Paper Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. DOI 10.3390/jcm8091402 ↗
Wen‐Chi Chou · 2 shared papers, 2019–2020 · strength 0.19
- Paper External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line ch… DOI 10.1016/j.pan.2019.11.001 ↗
- Paper Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. DOI 10.3390/jcm8091402 ↗
Pei‐Hung Chang · 2 shared papers, 2019–2020 · strength 0.19
- Paper External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line ch… DOI 10.1016/j.pan.2019.11.001 ↗
- Paper Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. DOI 10.3390/jcm8091402 ↗
Shao‐Ming Yu · 1 shared paper, 2020 · strength 0.11
- Paper External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line ch… DOI 10.1016/j.pan.2019.11.001 ↗
Yen‐Yang Chen · 1 shared paper, 2020 · strength 0.11
- Paper External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line ch… DOI 10.1016/j.pan.2019.11.001 ↗
Pei‐Wei Huang · 1 shared paper, 2019 · strength 0.09
- Paper Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. DOI 10.3390/jcm8091402 ↗
Chih-Po Hsu · 1 shared paper, 2016 · strength 0.06
- Paper Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. DOI 10.1097/md.0000000000004191 ↗
Shih-Chun Chang · 1 shared paper, 2016 · strength 0.06
- Paper Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. DOI 10.1097/md.0000000000004191 ↗
Chun‐Nan Yeh · 1 shared paper, 2016 · strength 0.06
- Paper Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. DOI 10.1097/md.0000000000004191 ↗
Tsann‐Long Hwang · 1 shared paper, 2016 · strength 0.06
- Paper Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. DOI 10.1097/md.0000000000004191 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.